EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery

Matthew W McGarrity iD, Paul MacPherson, Abby Li, Mark Naccarato, Peter Anderson, Darrell H S Tan iD

HIV Medicine · 2025-04 · 26 (4) · 643-649

DOI: 10.1111/hiv.13759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 15.01.2025. Verfasst von Matthew W McGarrity und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Bariatric Surgery, Adenine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research (CIHR), Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To measure concentrations of tenofovir diphosphate (TFV‐DP) in dried blood spots (DBS) among individuals taking tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC) or tenofovir alafenamide plus emtricitabine (TAF/FTC) who were scheduled to undergo or had already undergone bariatric surgery.

Methods

We enrolled pre‐exposure prophylaxis (PrEP) users attending clinics in Toronto or Ottawa who were undergoing or had undergone bariatric surgery. After participants completed a minimum of 7 days of consecutive PrEP dosing, we collected DBS samples immediately before they administered their next daily dose of PrEP. Participants who had already undergone bariatric surgery before enrolment provided a single sample at baseline only. One participant undergoing planned bariatric surgery provided samples preoperatively and on postoperative days 7, 28 and 84. TFV‐DP was measured by liquid chromatography tandem mass spectrometry. We compared results against the population range TFV‐DP at varying degrees of adherence and stratified by chronology of bariatric surgery, type of bariatric surgery and PrEP regimen.

Results

Of seven eligible participants, all were gay, cis‐gender men. Median age was 48 years (Q1–Q3: 44–51). Six participants underwent bariatric surgery before enrolment: four Roux‐en‐Y gastric bypass (RYGB) and two sleeve gastrectomy (SG). Four were taking TDF/FTC and two were taking TAF/FTC. All had therapeutic TFV‐DP concentrations, except for one TDF/FTC participant who underwent SG. One participant taking TAF/FTC enrolled before receiving RYGB and displayed a slight decrease in TFV‐DP over time, although all concentrations remained in the therapeutic range.

Conclusions

Tenofovir diphosphate concentrations were at or near therapeutic values in this small sample of men using oral PrEP who underwent RYGB or SG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsBariatric SurgeryAdenineAnti-HIV AgentsTenofovirOrganophosphatesHumansMaleAdultMiddle AgedFemaleEmtricitabineChromatography, LiquidTandem Mass Spectrometry

Stichwörter der Autor:innen

bariatric surgeryemtricitabinegastrointestinal absorptionpre‐exposure prophylaxistenofovir

Substanzen

Adeninetenofovir diphosphateAnti-HIV AgentsTenofovirOrganophosphatesEmtricitabine

Autor:innen und Institutionen

  • Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.
  • MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Division of Infectious Diseases, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Matthew W McGarrity, Darrell H S Tan

Förderung

  • CIHR
  • Canadian Institutes of Health Research (CIHR)
  • Canada Research Chairs

Zitieren

APA

McGarrity, M. W., MacPherson, P., Li, A., Naccarato, M., Anderson, P., & Tan, D. H. S. (2025). Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery. HIV Medicine, 26(4), 643-649. https://doi.org/10.1111/hiv.13759

Vancouver

McGarrity MW, MacPherson P, Li A, Naccarato M, Anderson P, Tan DHS. Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery. HIV Medicine. 2025;26(4):643-649. doi:10.1111/hiv.13759

BibTeX
@article{McGarrity2025,
  author = {McGarrity, Matthew W and MacPherson, Paul and Li, Abby and Naccarato, Mark and Anderson, Peter and Tan, Darrell H S},
  title = {Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery},
  journal = {HIV Medicine},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {643--649},
  doi = {10.1111/hiv.13759}
}
Kostenlos starten →